Floatz logo

IMMUNOGLOBULIN G1, ANTI-(HUMAN MACROPHAGE COLONY-STIMULATING FACTOR) (HUMAN-MUS MUSCULUS MONOCLONAL CLONE NVS220906 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL CLONE NVS220906 .KAPPA.-CHAIN, DIMER

Bone Metastases

Novartis Pharmaceuticalsmonoclonal_antibodyPhase 1/2Dormant
CC
42/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
27/ 100
Competitive Position
89/ 100

Competitive context

34 Active assets in the Bone Metastases cohort.

Asset / SponsorPhaseRating
Ibandronate
Kelly Fitzgerald, MD
Phase 4BBB
Denosumab
Kelly Fitzgerald, MD
Phase 4BBB
Zoledronate
Kelly Fitzgerald, MD
Phase 4BBB
RADIUM RA-223
University of California, San Francisco
Phase 3BB
Zometa
Sun Yat-sen University
Phase 4BB

View all 50 →

Same molecule, other indications

IMMUNOGLOBULIN G1, ANTI-(HUMAN MACROPHAGE COLONY-STIMULATING FACTOR) (HUMAN-MUS MUSCULUS MONOCLONAL CLONE NVS220906 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL CLONE NVS220906 .KAPPA.-CHAIN, DIMER is also rated in:

triple-negative breast carcinomaDormant
B
Indicative ·
58 / 100
View asset →
endometrial carcinomaDormant
CC
Indicative ·
44 / 100
View asset →
exocrine pancreatic carcinomaDormant
CC
Indicative ·
42 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →